Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: NANOCOMPOSIX, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-06-01 to 2022-05-31
Current total value of award: $300000
Description: EO14042: THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN AND SYNTHESIS A NEW PLGA BASED NANOPARTICLE WITH NANOPARTICLE WITH OPTIMAL PROTEIN-ADJUVANT FORMULATION COMBINING BOTH TARGETING AND CONTROLLED DELIVERY FOR IMMUNIZATION AGAINST HIV.